1. Introduction
Many individuals experience gastrointestinal issues when visiting high altitudes [
1]. Research indicates that the prevalence of these complaints among travelers to high altitudes via trains is 99%, a rate that significantly exceeds that of other conditions such as hypodynamia (77% of travelers), headaches (74%), and dizziness (71%). Gastrointestinal problems not only occur more frequently but also tend to persist longer and carry greater risks compared with non-gastrointestinal issues [
2]. Although the exact causes of gastrointestinal disturbances at high altitudes remain poorly understood, evidence suggests that damage to the intestinal barrier plays a crucial role in their development [
1,
3]. The intestinal barrier is primarily composed of chemical, biological, and physical barriers [
4], all of which can be significantly compromised by high-altitude exposure [
5,
6,
7]. While azithromycin has been reported to effectively reduce high-altitude diarrhea, its efficacy is variable among individuals [
8]. Furthermore, several agents, including glutamine [
9], vitamin E [
10], and butyrate [
11], have shown promise in mitigating high-altitude-induced intestinal damage in animal studies. In summary, there are currently very few medications available for alleviating gastrointestinal symptoms associated with high-altitude exposure.
Imbalances in gut microbiota have been linked to the development of gastrointestinal diseases [
12]. Research has demonstrated that exposure to high altitudes can alter the composition and structure of gut microbiota. Generally, high-altitude exposure results in an increase in the proportion of anaerobic bacteria and a decrease in facultative anaerobic bacteria [
13]. For example, after high-altitude exposure, the abundance of
Odoribacter,
Prevotella, and
Akkermansia increased, while the abundance of
Enterobacter,
Weissella,
Escherichia, and
Klebsiella decreased [
14,
15]. Numerous studies have highlighted differences in gut microbiota between low- and high-altitude exposures; however, few studies have specifically examined the differences in gut microbiota during the acute response phase compared with the acclimatization phase at high altitudes. One study noted that travelers transitioning from low to high altitude experienced these two phases, but it did not detail the differences in gut microbiota between them [
15]. We believe that investigating these differences could be valuable for identifying microbial factors that contribute to acclimatization at high altitudes. Additionally, the role of gut microbiota altered by high-altitude exposure in gastrointestinal diseases remains a topic of debate. Li et al., 2022 [
16] found that high-altitude exposure promoted the growth of Desulfovibrio in the intestines of mice. The phospholipid metabolites produced by Desulfovibrio were then presented by intestinal epithelial Cluster of Differentiation 1D, leading to the proliferation of Interleukin-17A-producing γδ T cells, which further aggravated intestinal injury [
16]. In contrast, Su et al., 2024 observed that high-altitude exposure increased the abundance of
Blautia in the human gut, and this increase was associated with improved gut health and acclimatization at high altitudes [
17]. Several factors may contribute to the discrepancies in these findings, including the host species studied, the duration and altitude of exposure, and the specific gut microbes examined in each study. These limited and inconsistent results suggest that much remains to be learned about the role of gut microbiota in intestinal barrier damage caused by high-altitude exposure.
Probiotics, which encompass both bacteria and yeast, are live microorganisms recognized for their beneficial effects on human health. Recently, there has been extensive research focused on probiotics, particularly their potential use as supplemental treatments for various intestinal diseases. Numerous clinical trials have shown that probiotics can positively influence gut microbiota, potentially aiding in the management of various intestinal conditions and promoting overall well-being [
18]. Common probiotics include species from the genera
Bacillus,
Bifidobacterium,
Clostridium,
Enterococcus,
Lactobacillus,
Saccharomyces, and
Streptococcus. Substantial evidence supports the efficacy of these probiotics in treating acute infectious diarrhea, antibiotic-associated diarrhea,
Clostridium difficile-associated diarrhea, hepatic encephalopathy, ulcerative colitis, irritable bowel syndrome, functional gastrointestinal disorders, and necrotizing enterocolitis [
19]. Notably, two prominent probiotics,
Bifidobacterium and
Lactobacillus, along with a less common bacterium,
Blautia, have been shown to alleviate intestinal disorders associated with high altitudes [
17,
20,
21]. Although the range of probiotics studied is limited, their benefits in addressing high-altitude-related intestinal issues warrant further investigation into additional probiotics in this context. This study focuses on probiotics that are adapted to, can survive in, and function effectively within the gut environment created by high-altitude stress, along with their potential mechanisms of action.
In this study, we tested the hypothesis that gut probiotics play a role in mitigating intestinal barrier damage caused by exposure to high altitudes. To investigate this, we conducted microbiome analyses of 49 fecal samples collected from volunteers during both the acute response and acclimatization phases at high altitudes with the aim of identifying potential probiotics. The identified probiotic was subsequently administered via gavage to the intestines of mice to evaluate its protective effects against intestinal barrier damage induced by high-altitude exposure. Additionally, we explored the underlying mechanisms through transcriptome analysis and non-targeted metabolomics. We also examined the beneficial effects of 2-ketoglutaric acid on intestinal barrier damage using mouse models. Our results support the hypothesis that F. duncaniae contributes to the reduction in intestinal barrier damage caused by high-altitude exposure by increasing the levels of 2-ketoglutaric acid.
2. Materials and Methods
2.1. Study Design and Volunteers
This study involved 12 female and 13 male volunteers, all over the age of 20. Participants reported no gastrointestinal abnormalities or diseases, were not taking any medications, and had not undergone a colonoscopy in the past three months. They traveled by train from a low altitude of approximately 100 m to a high altitude of about 3500 m, where they remained for 12 days. On the second day after arriving at the high altitude, the volunteers exhibited one or more symptoms associated with acute mountain sickness (AMS). On this day, a total of 25 fresh stool samples were collected and categorized as the unacclimatized group (acute response phase). After 12 days at high altitude, all AMS-related symptoms had nearly resolved, and an additional 24 fresh stool samples were collected on this day and classified as the acclimatized group (acclimatization phase). All fecal samples were stored at −80 °C for 16S rRNA sequencing.
2.2. Microbiome Analysis
Fecal samples collected from volunteers were immediately stored at −80 °C until microbiome analysis was conducted at Shanghai Majorbio Technology Co., Ltd. (Shanghai, China). The microbiome analysis was performed as previously described [
22], with some modifications; specifically, we calculated rarefaction curves and alpha diversity indices, including Chao1 richness and the Shannon index, using Mothur v1.30.2 [
23] based on the Operational Taxonomic Units (OTUs). To assess the similarities between microbial communities across different samples, we employed Partial Least Squares Discriminant Analysis (PLS-DA) using R (version 3.3.1). Additionally, the microbial dysbiosis index was utilized to evaluate the state of microbial dysbiosis.
2.3. Optimal Prebiotic Analysis of F. duncaniae
F. duncaniae was obtained from Ningbo Testobio Biotechnology Co., Ltd. (Ningbo, China) To cultivate F. duncaniae anaerobically, a modified reinforced clostridial broth was used, containing the following components: tryptose (10 g/L), beef extract (10 g/L), yeast extract (3 g/L), dextrose (5 g/L), NaCl (5 g/L), soluble starch (1 g/L), L-cysteine hydrochloride (0.5 g/L), and sodium acetate (3 g/L). The pH was maintained at 6.8 ± 0.2. Cultivation was conducted at 37 °C. Prior to use, all broths were treated to remove oxygen, ensuring an anaerobic environment for the culture. F. duncaniae strains in the logarithmic growth phase were diluted to an OD600 of 0.4. Subsequently, 10% of the diluted broth was added to two types of modified reinforced clostridial broth: one without dextrose and the other supplemented with one of the following carbon sources: 5 g/L of inulin (Yuanye Biotechnology, Shanghai, China), soybean oligosaccharide (Yuanye Biotechnology, Shanghai), fructooligosaccharide (Yuanye Biotechnology, Shanghai), galactooligosaccharide (Yuanye Biotechnology, Shanghai), konjac glucomannan (Yuanye Biotechnology, Shanghai), isomaltooligosaccharide (Yuanye Biotechnology, Shanghai), or dextrose (Yuanye Biotechnology, Shanghai). The broth was incubated at 37 °C for 24 h, with three replicates for each group. At the end of the incubation period, absorbance values were measured. Differences in absorbance values between the groups with various carbon sources and the group without dextrose were calculated to investigate the effects of different prebiotics on the growth of F. duncaniae.
2.4. Preparation of Probiotics for Gavage
F. duncaniae was cultured anaerobically in modified reinforced clostridial broth for 24 h at 37 °C. Following the cultivation period, the bacterial precipitate was collected via centrifugation and washed twice with sterile anaerobic PBS. The concentration of the strains was adjusted using sterile anaerobic PBS containing 20 mg/mL of inulin, resulting in a synbiotic with approximately 5 × 10
9 CFU/mL of
F. duncaniae [
24].
2.5. Animal Experiment
Healthy male C57BL/6 mice aged six weeks were obtained from Liaoning Changsheng Biotech Co., Ltd. (Shenyang, China). They were housed in a controlled environment with a temperature of 20 ± 5 °C and a relative humidity of 50 ± 5% at a low altitude (below 500 m). The mice were maintained on a 12-h light/dark cycle and had unlimited access to food and water. Prior to the commencement of the experiment, all mice underwent a seven-day acclimation period.
To determine the optimal duration for modeling, the mice were randomly divided into three groups: a normoxia control (NC) group, a hypoxia exposure group for 5 days (H5D), and a hypoxia exposure group for 10 days (H10D). Each group consisted of five mice. The NC group received sterile PBS administered orally once daily and remained in a normoxic environment for the entire 10 days. The H5D group was kept in a normoxic environment for the first 5 days, followed by 5 days in a hypobaric chamber (Yuyan Instruments, Shanghai, China) at a simulated altitude of 6500 m, while also receiving sterile PBS administered orally once daily. The H10D group received sterile PBS administered orally once daily and remained in the hypobaric chamber at a simulated altitude of 6500 m for 10 days.
To investigate the effects of F. duncaniae on intestinal barrier damage caused by high-altitude exposure, the mice were randomly divided into three groups: the normoxia control group (NC), the hypoxia group (H), and the hypoxia + F. duncaniae and inulin group (HF). Each group comprised eight mice. The mice in the NC group received sterile anaerobic PBS administered orally once daily and remained in a normoxic environment for 17 days. The mice in the H group received sterile anaerobic PBS administered orally once daily and were housed in a normoxic environment for the first seven days, followed by 10 days in a hypobaric chamber at a simulated altitude of 6500 m, continuing to receive sterile anaerobic PBS administered orally once daily. The mice in the HF group were treated with F. duncaniae and inulin once daily, remaining in a normoxic environment for seven days, followed by 10 days in the hypobaric chamber at a simulated altitude of 6500 m, during which they continued to receive F. duncaniae and inulin administered orally once daily.
In the experiment involving treatment with 2-ketoglutaric acid, mice were randomly divided into three groups after a period of acclimatization: the normoxia control (NC) group, the hypoxia (H) group, and the hypoxia + 2-ketoglutaric acid (H2K) group. Each group comprised eight mice. In the NC group, the mice were administered sterile PBS orally once daily and kept in a normoxic environment for 10 days. The mice in the H group also received sterile PBS administered orally once daily but were housed in a hypobaric chamber simulating an altitude of 6500 m for the same duration. The mice in the H2K group were treated with 10 mg/kg of 2-ketoglutaric acid [
25] via gavage once daily, received 0.05% 2-ketoglutaric acid in their drinking water, and remained in the hypobaric chamber at a simulated altitude of 6500 m for 10 days. The gavage volume for all the mouse experiments was set at 10 mL/kg. After the treatment period, all mice were euthanized under isoflurane anesthesia, and relevant samples were collected for subsequent analyses.
2.6. Real-Time PCR Assay
Cecal contents were collected and stored at −80 °C for the quantitative analysis of
F. duncaniae abundance. DNA was extracted from the cecal contents using the FastPure Stool DNA Isolation Kit (MJYH, Shenzhen, China) according to the manufacturer’s instructions. The qPCR primer sets used are listed in
Table S1. Real-time PCR (RT-PCR) assays were conducted in 96-well optical plates on an ABI 7300 fluorescent quantitative PCR instrument (Applied Biosystems, Waltham, MA, USA). The reaction mixture consisted of 5 μL of 2× ChamQ SYBR Color qPCR Master Mix (Nuoweizan, Nanjing, China), 1 μL of template DNA, 0.4 μL of 5 μM forward primer, 0.4 μL of 5 μM reverse primer, 0.2 μL of 50× ROX Reference Dye 1, and 3 μL of double-distilled H
2O. The PCR cycling conditions included an initial denaturation at 95 °C for 3 min, followed by 40 cycles of melting at 95 °C for 5 s, annealing at 58 °C for 30 s, and a final extension at 72 °C for 1 min. The quantity of target DNA was determined by comparing it with serially diluted standards tested on the same plate. Bacterial abundance was expressed as log
10 copies per gram of cecal contents.
Total RNA was isolated from ileum tissues using the MJZol total RNA extraction kit (Majorbio, Shanghai, China) to verify the expression of the
Nfkbia and
Fos genes. cDNA was reverse transcribed using the HiScript Q RT SuperMix for qPCR (+gDNA wiper) Synthesis Kit (Vazyme Biotech Co., Ltd., Nanjing, China) following the manufacturer’s instructions. RT-PCR was performed in triplicate for each gene, and the GAPDH gene was used as an internal standard. All paired primers used for RT-PCR are listed in
Table S1. RT-PCR assays were conducted on a QuantStudio
TM 5384-well real-time PCR system (Applied Biosystems, Waltham, MA, USA). The reaction mixture comprised 5 μL of 2× ChamQ SYBR Color qPCR Master Mix (Nuoweizan, Nanjing, China), 1 μL of template cDNA, 0.4 μL of 5 μM forward primer, 0.4 μL of 5 μM reverse primer, 0.2 μL of 50× ROX Reference Dye 2, and 3 μL of double-distilled H
2O. The PCR cycling conditions included an initial denaturation at 95 °C for 5 min, followed by 35 cycles of melting at 95 °C for 30 s, annealing at 55 °C for 30 s, and a final extension at 72 °C for 1 min. Relative transcription levels were quantified using the 2
−ΔΔCT method.
2.7. Intestinal Permeability Analysis
Intestinal permeability was assessed using the 3–5 kDa fluorescein isothiocyanate (FITC)-dextran test (BioDuly, Nanjing, China), following previously established methods [
26]. In summary, FITC-dextran (600 mg/kg body weight) was administered to mice via oral gavage four hours prior to sacrifice. Subsequently, sera were obtained by centrifuging the samples at 2500 rpm for 20 min at 4 °C. A volume of 100 μL of each serum sample was transferred to a 96-well microplate. If the serum collected from an individual mouse was less than 100 μL, sera from two mice in the same group were combined to form a single sample. Fluorescence was measured at an excitation wavelength of 485 nm and an emission wavelength of 528 nm, and the concentration of FITC-dextran was calculated using a standard curve (y = 2.1085x − 0.4255, R
2 = 0.9997).
2.8. H&E and PAS Staining
A portion of the ileum was collected and preserved in 4% paraformaldehyde (Solarbio, Beijing, China). The sample was embedded in paraffin and sectioned into 3–4 μm slices. These slices were stained using the H&E Staining Kit (Servicebio, Wuhan, China) and the PAS dye solution set (Servicebio, Wuhan, China), following the manufacturer’s specifications. The stained sections were examined under a light microscope. Pathological changes were assessed by measuring the height of the intestinal villi and the thickness of the mucosa. Villi height was measured from the neck of the crypt to the tip of the villus using IMAGEJ, version 1.80, with a minimum of 15 villi measured for each sample. The number of goblet cells was evaluated in non-consecutive, randomly chosen histological fields (5 per slide). Two experienced pathologists, blinded to group identities, conducted pathological examinations of the specimens.
2.9. Immunohistochemistry Staining
Paraffin sections were deparaffinized in water, and antigen retrieval was performed using a Tris-EDTA buffer in a microwave oven. After cooling, the sections were washed three times with PBS (pH 7.4), with each wash lasting 5 min. They were then incubated in 3% hydrogen peroxide for 25 min to quench endogenous peroxidase activity, followed by three additional washes with PBS. Next, the sections were blocked with 3% BSA for 30 min. The sections were incubated overnight at 4 °C with primary antibodies against ZO-1 (GB115686, 1:500, Servicebio) or occludin (GB111401, 1:500, Servicebio). After washing with PBS three times, the sections were incubated for 50 min with an HRP-labeled goat anti-rabbit IgG secondary antibody (GB23303, 1:200, Servicebio). Following this, DAB stain (Servicebio, Wuhan, China) was added for color development, and the nuclei were re-stained with hematoxylin (Servicebio, Wuhan, China). The sections were then sealed with Rhamsan gum (Servicebio, Wuhan, China). Finally, images were captured and recorded using a Nikon Eclipse E100 microscope (Nikon, Tokyo, Japan), and quantitative analysis of the images was performed using the Aipathwell v2 software (ServiceBio, Wuhan, China).
2.10. TUNEL Staining
Apoptotic cells in the ileum tissues were detected using a TUNEL assay kit (Servicebio, G1501, Wuhan, China) according to the manufacturer’s instructions. Fluorescence signals were observed and recorded with a NIKON ECLIPSE C1 Fluorescence Microscope. Quantitative analysis was performed using the Aipathwell software (ServiceBio, Wuhan, China).
2.11. Untargeted Metabolomics Analysis
Untargeted metabolomics analysis was conducted at Shanghai Majorbio Technology Co., Ltd. Metabolite extraction from cecum contents was performed as previously described [
27]. LC-MS/MS analysis utilized a SCIEX UHPLC-Triple TOF 6600 system (SCIEX, Framingham, MA, USA), employing the same column and mobile phases as outlined earlier [
27]. However, in this study, the column temperature was set to 45 °C. The UPLC system was coupled to a quadrupole-time-of-flight mass spectrometer equipped with an electrospray ionization (ESI) source, operating in both positive and negative modes. The optimal mass spectrometry conditions for this study were as follows: source temperature at 500 °C; curtain gas at 35 psi; ion source gas 1 at 50 psi and gas 2 at 50 psi; ion-spray voltage floating at −4500 V in negative mode and 5500 V in positive mode; declustering potential at 80 V; and collision energy set to 40 ± 20 eV for MS/MS. Data acquisition was performed using the Information Dependent Acquisition mode, and detection occurred over a mass range of 50–1200
m/
z. The processing of raw LC/MS data and identification of metabolites were completed as previously described [
27]. The data matrix obtained from the database search was uploaded to the Majorbio cloud platform for data analysis [
27]. The R package “ropls” (Version 1.6.2) was used to conduct Partial Least Squares Discriminant Analysis (PLS-DA) and Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA). This analysis included a 7-cycle interactive validation to assess model stability. Metabolites with a Variable Importance in Projection (VIP) greater than 1 and a
p-value less than 0.05 were identified as significantly different based on the results from the OPLS-DA model and Student’s
t-test. Additionally, pathway analysis using the KEGG database was performed to map these differential metabolites between the two groups to their relevant biochemical pathways.
2.12. Measurement of AST and IDH Activities, as Well as the Levels of 2-Ketoglutaric Acid and Total Protein
The enzymatic activities of aspartate aminotransferase (AST) and isocitrate dehydrogenase (IDH) in the cecal contents were measured using an Aspartate Aminotransferase Assay Kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) and an Isocitrate Dehydrogenase Activity Assay Kit with WST-8 (Beyotime, Haimen, China), respectively. The total protein concentration in the cecal contents was determined using a BCA Protein Assay Kit (BCM Biotech, Shanghai, China). Additionally, the levels of 2-ketoglutaric acid in the cecal contents were assessed with an Amplex Red α-Ketoglutarate Assay Kit (Beyotime, Haimen, China). All the procedures were performed following the instructions provided in the reagent kits, and the results were read using an ELX800 universal microplate reader (Bio-Tek Instruments Inc., Winooski, VT, USA).
2.13. Transcriptome Analysis
Total RNA extraction from the ileum, library preparation, sequencing, quality control, and read mapping were conducted at Shanghai Majorbio Bio-pharm Biotechnology Co., Ltd., as previously described [
28]. Transcript expression levels were calculated using the transcripts per million reads (TPM) method. Gene abundance was quantified with RSEM, and differential expression analysis was performed using DESeq2. Genes with a log
2 fold change (|log
2FC|) ≥ 2 and a false discovery rate (FDR) ≤ 0.05 were considered significantly differentially expressed genes (DEGs). Additionally, functional enrichment analysis, including Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG), was performed to identify DEGs that were significantly enriched in specific GO terms and metabolic pathways. GO functional enrichment and KEGG pathway analyses were carried out using Goatools (Version 1.4.4) and KOBAS (Version 2.1.1), respectively.
2.14. Statistical Analysis
Statistical analysis was conducted using SPSS version 19.0 software, with data presented as mean ± standard deviation. For data following a normal distribution, comparisons were made using a two-tailed Student’s t-test or a one-way ANOVA. In cases of non-parametric distributions, the Wilcoxon rank-sum test was employed for group comparisons.
4. Discussion
Common probiotics are widely recognized for their role in supporting gut health. However, exposure to high altitudes significantly alters the intestinal microenvironment, which may hinder the survival of certain common probiotics [
29]. Therefore, it is crucial to identify specific gut microbiota that can adapt to these changes and play a probiotic role, particularly in preventing and treating intestinal barrier damage at high altitudes. Investigating the differences in gut microbiota between acculturated and unacculturated individuals living at high altitudes may help uncover these specific microorganisms. In our study, we examined gut microbiota during the acute response and acclimatization phases in volunteers who traveled from low to high altitude. We found that many opportunistic pathogens significantly increased during the acute response phase, leading us to speculate that these pathogens may be associated with human inadaptation to high-altitude conditions. Notably, we observed a significant increase in the abundance of
F. prausnitzii during the acclimatization phase. Research indicates that
F. prausnitzii is the most prevalent bacterium in the intestines of healthy adults, comprising over 5% of the total bacterial population. Administration of the
F. prausnitzii strain A2-165, along with its culture supernatant, has been shown to protect against colitis induced by 2,4,6-trinitrobenzenesulfonic acid in mice [
30]. This protective effect is primarily attributed to its potent anti-inflammatory properties [
30]. Additionally, supplementation with
F. prausnitzii can prevent intestinal barrier damage associated with sleep deprivation or acute myeloid leukemia, a benefit linked to the bacterium’s butyrate production [
31,
32]. Recently, new species of
Faecalibacterium have been identified and some strains of
F. prausnitzii isolated from human feces, including the reference strain A2-165, have been reclassified as
F. duncaniae [
33,
34]. However, the role and mechanisms of action of
Faecalibacterium in intestinal damage caused by high altitudes remain unclear.
Exposure to high altitudes often results in gastrointestinal issues, although the exact causes are not fully understood. One possible explanation is that hypoxia can damage the intestinal barrier [
1]. Research has shown that rodents exposed to hypoxia experience significant injury to epithelial cells and a compromised intestinal barrier, resulting in increased permeability and bacterial translocation [
1]. In a study by Karl et al., 2018, increased intestinal permeability was observed in a group of 17 healthy, physically active, but unacclimatized men after a rapid 22-day exposure to an altitude of 4300 m [
35]. Our findings also demonstrated that high-altitude exposure induced intestinal barrier damage in mice, consistent with previous research. Interestingly, we discovered that supplementation with
F. duncaniae in mice reduced gut barrier damage and decreased permeability. These results suggest that
F. duncaniae may function as a probiotic bacterium that helps mitigate intestinal barrier damage caused by high altitude and could facilitate human adaptation to high-altitude environments. Additionally, we observed a significant increase in the relative abundance of several other bacterial species, such as
Lachnospira,
Subdoligranulum, and
Anaerostipes caccae DSM 14662, during the acclimatization phase compared with the acute response phase. Previous studies have indicated that
Subdoligranulum is beneficial for alleviating necrotizing enterocolitis [
36], while
Anaerostipes caccae is recognized as an important butyrate-producing bacterium [
37]. This information suggests that studying the synergistic effects of these bacteria and
F. duncaniae in alleviating intestinal diseases induced by high-altitude exposure holds great potential for future applications.
Previous studies have often linked the probiotic effects of
Faecalibacterium to its ability to produce butyric acid [
31,
32], while other active components have frequently been overlooked. In this study, we observed that exposure to high altitude significantly reduced the levels of 2-ketoglutaric acid in cecal contents. However, supplementation with
F. duncaniae resulted in a notable recovery of 2-ketoglutaric acid levels. These findings suggest that restoring 2-ketoglutaric acid levels may be beneficial. As an intermediate in the tricarboxylic acid (TCA) cycle, 2-ketoglutaric acid plays a crucial role in energy metabolism as well as the metabolism of carbon and nitrogen, underscoring its multiple important functions. Within the digestive system, 2-ketoglutaric acid contributes to the TCA cycle, providing energy for intestinal epithelial cells and helping to maintain intestinal mucosal integrity [
38]. Previous research has demonstrated that 2-ketoglutaric acid reduces the production of reactive oxygen species, inflammation, and apoptosis [
38,
39]. Notably, exposure to high altitude is associated with limited energy metabolism, increased oxidative stress, elevated inflammation, and heightened apoptosis, all strongly linked to altitude-induced diseases [
40]. In our study, we found that additional supplementation of 2-ketoglutaric acid alleviated hypoxia-induced intestinal barrier damage and reduced intestinal cell apoptosis. Due to its multiple functions, 2-ketoglutaric acid is recognized as a safe nutritional supplement in clinical applications, exhibiting protective effects against various diseases, including aging, muscle mass loss, osteoporosis, neurodegenerative diseases, and cardiovascular diseases [
41]. However, the role of 2-ketoglutaric acid in treating gastrointestinal disorders induced by high-altitude exposure has not been previously established. The results of this study suggest that 2-ketoglutaric acid holds significant potential as a nutritional supplement for the treatment or prevention of gastrointestinal disorders associated with high-altitude exposure. Additionally, to explore the mechanism through which
F. duncaniae restores 2-ketoglutaric acid levels, we examined KEGG databases and found that it can express AST and IDH enzymes. Both of these enzymes catalyze specific substrates to produce 2-ketoglutaric acid. Our analysis demonstrated that supplementation with
F. duncaniae significantly enhanced the activity of these two enzymes in cecal contents.
We analyzed transcriptome data to investigate the mechanisms underlying intestinal barrier damage caused by high-altitude exposure and how
F. duncaniae may mitigate this damage at the molecular level. GO enrichment analysis revealed that many DEGs were significantly enriched in various immune-related pathways, suggesting a link between the immune system and intestinal barrier damage resulting from high-altitude exposure. Interestingly, 2-ketoglutaric acid, known as an immune nutrient factor, plays a crucial role in general immune metabolism. As a glutamine homolog, 2-ketoglutaric acid possesses immuno-enhancing properties, maintaining the gut barrier, increasing the activity of immune cells and neutrophils, promoting phagocytosis, and reducing bacterial translocation in vivo [
42]. We hypothesize that
F. duncaniae may modulate mouse immunity by restoring ketoglutaric acid levels, which could be beneficial in protecting the intestinal barrier from damage caused by high-altitude exposure. Furthermore, KEGG enrichment analysis indicated that eight DEGs between the NC and H groups were significantly enriched in the Calcium Signaling Pathway. Previous studies have shown that hypoxia can disrupt intracellular calcium levels [
43], potentially leading to calcium overload, mitochondrial uncoupling, decreased ATP synthesis, and, ultimately, cell death [
44]. Additionally, the calcium signaling pathway plays a critical role in regulating cell apoptosis [
45,
46]. Therefore, we speculate that hypoxia induces intestinal cell apoptosis through the calcium signaling pathway, exacerbating intestinal barrier damage. In contrast, DEGs between the HF and H groups exhibited significant enrichment in several pathways, including the PPAR Signaling Pathway, Mineral Absorption, Regulation of Lipolysis in Adipocytes, and Arachidonic Acid Metabolism. Notably, the PPAR Signaling Pathway, Regulation of Lipolysis in Adipocytes, and Arachidonic Acid Metabolism are all associated with fat metabolism, suggesting that fat metabolism may play a crucial role in preventing intestinal barrier damage, highlighting a valuable area for future research. The Mineral Absorption pathway is associated with calcium absorption and may contribute to regulating calcium homeostasis within cells. Interestingly, we identified two DEGs,
Nfkbia and
Fos, that were enriched in the apoptosis pathway, with their abundance significantly decreasing after treatment with
F. duncaniae. Inhibition of
Nfkbia and
Fos expression has been shown to promote cell survival [
47,
48,
49]. Thus, we speculate that
F. duncaniae may mitigate intestinal barrier damage caused by high-altitude exposure by regulating both calcium homeostasis and apoptosis.